Description
CH7057288 is a potent and selective TRK inhibitor.
Product information
CAS Number: 2095616-82-1
Molecular Weight: 569.67
Formula: C32H31N3O5S
Chemical Name: N-tert-butyl-2-(2-{5-methanesulfonamido-2,2-dimethyl-9-oxo-17-oxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-1(10),3,5,7,11,13,15-heptaen-14-yl}ethynyl)-6-methylpyridine-4-carboxamide
Smiles: CC(C)(C)NC(=O)C1C=C(C#CC2C=C3OC4=C(C(=O)C5=CC=C(C=C5C4(C)C)NS(C)(=O)=O)C3=CC=2)N=C(C)C=1
InChiKey: DCGOHGQJHJXBGW-UHFFFAOYSA-N
InChi: InChI=1S/C32H31N3O5S/c1-18-14-20(30(37)34-31(2,3)4)16-21(33-18)10-8-19-9-12-24-26(15-19)40-29-27(24)28(36)23-13-11-22(35-41(7,38)39)17-25(23)32(29,5)6/h9,11-17,35H,1-7H3,(H,34,37)
Technical Data
Appearance: Solid Power
Purity: ≥98% (or refer to the Certificate of Analysis)
Solubility: DMSO : ≥ 34 mg/mL (59.68 mM).
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life: ≥12 months if stored properly.
Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.
Drug Formulation: To be determined
HS Tariff Code: 382200
How to use
In Vitro:
CH7057288 induces regression of intracranial tumors and greatly improves event-free survival in an intracranial implantation model mimicking brain metastasis. CH7057288 can be a promising therapeutic agent for TRK fusion-positive cancer. TRK receptor tyrosine kinases are expressed as fusion proteins encoded by various fusion genes across a wide variety of cancer types, including lung and colorectal cancer.
Products are for research use only. Not for human use.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.